Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic nephropathy? Genetic predisposition to essential hypertension has been proposed as a risk factor for the development of diabetic nephropathy in type 1 (insulin-dependent) diabetes mellitus. An increased sodium-lithium countertransport activity (NaLiCT) has been suggested as a genetic marker for essential hypertension. We therefore evaluated NaLiCT in diabetic patients with (N = 39) or without (N 23) diabetic nephropathy (DNP), patients with nondiabetic renal diseases (N = 42) and in healthy controls (N = 24). The NaLiCT was elevated in both diabetic patient groups compared to healthy controls (median 244; range 134 to 390 mol liter cells' hr), but was not different in patients with DNP (median 314; range 162 to 676), without DNP (median 325; range 189 to 627) and patients with non-diabetic renal disease (median 300; range 142 to 655). The genetic predisposition to DNP is illustrated by the fact that diabetic sibs of probands with DNP showed a higher occurrence of DNP than diabetic sibs of patients without DNP. We analyzed whether familial DNP clustered with an increased NaLiCT. The NaLiCT in sibs concordant for the presence of DNP (N = 10; median 307; range 217 to 428 mo1 liter cel1s' hC') was not significantly different from that in sibs concordant for absence of DNP (N = 15; median 279; range 189 to 442). We conclude that erythrocyte sodium-lithium countertransport activity cannot be used as a marker to identify patients at risk for the development of diabetic nephropathy.
Approximately one third of the patients with type 1 (insulindependent) diabetes mellitus develop the clinical syndrome of diabetic nephropathy (DNP), mostly 15 to 20 years after the onset of diabetes [1] . The development of DNP is heralded by microalbuminuria and a rise in blood pressure [2] . At present there are no explanations why some patients develop DNP and others do not [1, 3] . The susceptibility to DNP cannot solely be explained by differences in glycemic control [4] , which suggests that other factors are involved. Even at the early stages, DNP is accompanied by a rise in blood pressure [5] , and some authors have already observed such a rise before any impairment of kidney function was detectable [2, 6] . Others, however, argue that the rise in blood pressure is rather the consequence of DNP than a causative factor [7] .
Recently, Viberti, Keen and Wiseman have found that nondiabetic parents of patients with DNP had higher blood pressure levels, suggesting that a familial predisposition to hypertension is a risk factor for the development of DNP [8] . This contention was corroborated by findings of two independent groups of © 1992 by the International Society of Nephrology 862 investigators, who showed that erythrocyte sodium-lithium countertransport activity (NaLiCT), a genetic marker for essential hypertension in non-diabetic patients [9] , is increased in patients with overt DNP compared to diabetics without DNP [10, 11] and patients with non-diabetic renal disease [11] . Subsequently, an increased NaL1CT was also found in patients with microalbumin. ui-ia [12] , who are at high risk for progression to overt DNP [6] .
Finally, an increased NaLiCT in type 1 diabetic patients with normoalbuminui-ia and normotension appeared to be associated with an increased glomerular filtration rate and filtration fraction [13] . Since hyperfiltration is regarded as one of the possible pathophysiological mechanisms in the development of DNP, these findings suggest that patients who are at risk for the developmenl of DNP can be identified by an increased NaLiCT. Based on these observations, the concept was formulated that the susceptibility to DNP in type I diabetes may be associated with a genetic predisposition to essential hypertension, and that an increased NaLiCT could be used as a marker to identify patients at risk for DNP. We measured NaLiCT in patients with type I diabetes with and without DNP, patients with various non-diabetic renal diseases and normal healthy control subjects. Furthermore, a second study was undertaken in which we analyzed NaLiCT in familial diabetes mellitus. It has been reported that development of DNP is clustered in families, since diabetic sibs of patients with DNP show a higher frequency of DNP than diabetic sibs of patients without DNP [141, which supports the hypothesis that genetic factors are involved in the susceptibility to DNP. We investigated whether familial DNP clustered with an increased NaLiCT by measuring NaLiCT in diabetic sibs concordant for the presence or absence of DNP.
Our results [15, 16] appeared to be at variance with those mentioned earlier [10, 11] , but were similar to those reported recently by Jensen et al [17] . Like Jensen we used LiHCO3 to load erythrocytes with lithium, while Krolewski et al [101 and Mangili et al [11] used LiC1. To exclude that this discrepancy in NaLiCT activity in DNP was due to differences in methodology, we measured NaLiCT after both loading conditions (LiHCO3 and LiC1) in healthy controls and in diabetic patients with and without DNP.
Methods

Patients
Study I. To study the relation between NaLiCT and DNP, patients with and without diabetic nephropathy were recruited from the diabetology outpatient clinic. All patients had type I (insulin-dependent) diabetes mellitus. Duration of diabetes in the patients without diabetic nephropathy had to be at least 15 years. NaLiCT was also measured in a group of patients with various non-diabetic renal diseases who were recruited from the nephrology outpatient clinic. The original renal disease in these patients was respectively: chronic pyelonephritis (N 5), adult polycystic kidney disease (N = 6), interstitial nephritis (N = 3), hypertensive glomerulosclerosis (N = 2), chronic glomerulonephritis (N = 3), focal glomerulonephritis (N = 7), Alport's disease (N = 1), membranous glomerulonephritis (N = 5), IgA nephropathy (N = 5), and focal and segmental glomerulosclerosis (N = 5). A control group of 24 healthy subjects was also studied. The control subjects all had a normal blood pressure, normal renal function and no proteinuria. All studied patients and controls were Caucasians. The results of this study have partly been published elsewhere [15] . In this report 11 diabetic patients were additionally studied.
Study II. To analyze whether familial DNP clusters with an increased NaLiCT, patients with type 1 diabetes mellitus of at least 15 years duration who also had a living sib with type 1 diabetes for at least 15 years were identified and enrolled in this study. The results of the NaLiCT measurements in these patients are included in study I.
Methods
Diabetic nephropathy is defined as the presence of an albumin excretion rate (AER) > 20 g/min in each of two timed, overnight, sterile, non-ketcic urine collections. Incipient nephropathy is defined as an AER between 20 and 200 tg/min and overt nephropathy as an AER > 200 g/min. The albumin concentration was measured by laser immunonephelometry as described previously [18] [interassay coefficient of variation: 3% for high (>70 ,tLg/ml) and 10% for low albumin concentrations]. Other kidney or urinary tract diseases were excluded by clinical or laboratory parameters. In the patients with nondiabetic renal disease, proteinuria was assessed by measurement of the protein/creatinine ratio (g/mmol of creatinine X 10) in a fresh morning sample [19] ; protein concentration was measured with the biuret method and creatinine with the Jaffé method. Blood pressure was measured after five minutes of recumbency with a standard mercury sphygmomanometer.
Hypertension was defined as a mean arterial pressure (MAP)> 110 mm Hg or the use of antihypertensive drugs, MAP was calculated as diastolic blood pressure plus one third of the pulse pressure. In all patients NaLiCT, blood pressure, HbAIC, albumin excretion rate (AER), serum creatinine and body weight were measured. In the diabetic patients serum cholesterol was also measured. HbAIC was analyzed by HPLC (normal value 4.3 to 6.3%).
Measurement of sodium-lithium countertransport Venous blood was drawn between 08.00 and 10.00 a.m. and all measurements were performed on the day of the blood collection. The blood was collected in two 10 ml heparin-coated tubes for duplicate measurement of NaLiCT, Measurement of NaLiCT after loading with lithium bicarbonate. NaLiCT was measured according to the method described by Ibsen et al [20] . All steps were performed in duplicate. The whole assay was carried out on ice with cooled (4°C) media, except for the effiux measurements, which were performed in a water bath at 37°C. From the blood samples plasma and buffy coat were removed and the erythrocytes were washed three times in a magnesium chloride medium (75 m magnesium chloride, 85 m sucrose, 10 m glucose, 10 mM Tris-MOPS, pH 7.4) and after centrifugation (5 mm 1500 g at 4°C) resuspended in the lithium loading medium (150 mi lithium bicarbonate, 5 m potassium chloride, 10 m glucose) to a hematocrit of 20%. The medium was made from lithium carbonate and titrated with CO2 to pH 7.4. The erythrocytes were incubated in this medium during 20 minutes at 37°C. After loading, the cells were washed five times in a potassium chloride medium (150 m potassium chloride, 10 m glucose, 0.1 mM ouabain, 10 mrvi Tris-MOPS, pH 7.4). After each wash step the cells were centrifuged three minutes at 1500 g at 4°C.
After washing a 35% erythrocyte suspension was made in the potassium medium. A sample was taken for measurement of the intracellular lithium concentration and for the measurement of hemoglobin concentration and mean cell hemoglobin concentration (Technicon HI). For the lithium efilux measurements 0.5 ml of the erythrocyte suspension was incubated at 37°C in parallel in either 3.5 ml sodium chloride medium (150 mM sodium chloride, 10 m glucose, 0.1 mti ouabain, 10 mM Tris-MOPS) or in 3.5 ml of the above-mentioned potassium chloride medium. The hematocrit at which the countertransport measurement took place was therefore 4%. After 30, 60 and 90 minutes, incubation in either medium was stopped by placing the tubes on ice for two minutes, and subsequent centrifugation at 1500 g for three minutes at 4°C. Lithium concentration in the supernatant was measured by atomic absorption spectrophotometry (Perkin Elmer 5000). The standard solutions contained 0.25 to 2.5 m lithium.
For the calculation of the NaLiCT, it is assumed that a linear relation exists between the sodium-simulated lithium efflux over time. We measured three time points (30, Sodium-lithium countertransport was calculated from the difference between the lithium effiux rate in the sodium chloride medium and in the potassium chloride medium. The intra-assay variation of our assay is 5%, while the inter-assay variation was 13%. This inter-assay variation, representing both inter-test variability as well as biological variability, was measured by performing 4 to 6 measurements during a six week period in six individuals. These figures are comparable to those reported in the literature [21, 22] .
Measurement of NaLiCT after loading with lithium chloride. This method was carried out by a procedure identical to that described above except for the loading conditions. Erythrocytes were suspended in lithium chloride medium (150 mM effiux measurements were performed in the same way as mentioned above. In 17 subjects NaLiCT measurements obtained with both methods were compared. In three subjects the change in intracellular bicarbonate concentration was measured after loading with LiHCO3 or LiCI and the complete washing cycle.
Statistical analysis
All results are expressed as mean sn or as median (range) when the data were not normally distributed. Wilcoxon's rank sum test for unpaired data was applied for comparison of the groups. With Bonferroni adjustment for multiple comparisons the significance level was set at P < 0.01. Correlations were measured as Spearman's correlation coefficients in all cases. Comparison of the two methods for measurement of NaLiCT was performed according to the linear regression analysis of Passing and Bablok which was developed to compare analytical procedures [23J.
Results
Validation of NaLICT measurement Before measurement of the sodium stimulated lithium-efilux an intracellular lithium concentration should be reached of at least 5 mmol/liter, since at that concentration the countertransport is saturated [20] . After loading of erythroctyes with LiHCO3 or with LiCl, we analyzed the intracellular concentrations obtained with both methods. The lithium-influx as a function of the incubation time is shown in Figure 1 . From this figure it is clear that the critical intracellular lithium concentration of 5 mmol/liter was reached much faster by loading with LiHCO3 than by LiCl (20 vs. 180 mm). During incubation with LiHCO3, Li is transported into the cell as LiCO in exchange for Cl via the anion exchanger [24] , but under these conditions, HCO is also exchanged for C1. To evaluate this change we measured the change in the intracellular HCO concentration after loading with LiHCO3 or L1CI. As can be seen in Figure 2 , there was indeed an increase in the intracellular HCO; concentration after loading with HCO, but during the wash cycles with KCI this was corrected via the same anion exchange. At the moment the actual countertransport measureIncubation time, minutes ment began, the intracellular HCO3 concentration was again identical to that of cells loaded with LiCI. Also, the intracellular C1 concentration was identical after the washing procedure in cells either loaded with LiHCO or LiCI (data not shown).
Measurements of the Li efflux in a KCI medium (spontaneous lithium leakage) or in a NaCl medium (spontaneous leakage and sodium-lithium exchange) after loading with LiHCO3 or LiCl were completely identical (Fig. 3) , To further substantiate this, we measured NaLiCT with both loading procedures in healthy subjects and in diabetic patients with and without DNP. As can be seen in Table I the magnitude of the NaLiCT was identical for both methods. If we compared NaLiCT activities obtained with the two different loading conditions according to the linear regression model of Passing and Bablok [23] , we found an R2 of 0.97 (Fig. 4) , indicating that the two loading procedures yielded identical results.
NaLiCT and diabetic nephropathy The clinical and laboratory data of the patients in study I are shown in Table 2 . No difference was found in age or duration of diabetes in the diabetic patients with or without nephropathy. There was a male preponderance in the renal disease groups 
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After loading After 1 wash After 5 washes (DNP+ and RD). This is in line with the observations that male sex is prevalent in patients with either diabetic or non-diabetic renal disease [25] . By definition the patients with DNP had a higher AER and, as expected, higher serum creatinine levels and blood pressure readings. Cholesterol levels were equal in both diabetic groups. From the patients with DNP, 15 patients had incipient diabetic nephropathy (median AER 72; range 27 to 159 rg/min) and 24 patients had overt diabetic nephropathy with a median AER of 432 (range 219 to 2846) /.tg/min. In patients with DNP, the MAP was significantly higher than in liabetic patients without DNP (P < 0.001). Of the 24 patients with overt DNP, 15 had hypertension, and one of the patients with incipient DNP had hypertension. None of the diabetic patients without DNP had hypertension. Of the patients with non-diabetic renal disease (RD), 26 had renal disease which was glomerular in origin and 16 non-glomerular. These two groups Dnly differed for the magnitude of the proteinuria [median 3.8 (0.1 to 19.7) vs. 0.8 (0.1 to 5.8) g/mmol creatinine; P < 0.011. Hypertension was present to the same extent in patients with glomerular RD (21/26, 81%) and in the patients with nonglomerular RD (13/16, 81%). The blood pressure level was higher in the non-glomerular group (MAP 112 13 vs. 104 9 mm Hg; P < 0.02). The serum creatinine was significantly higher in the RD patients than in either group of diabetic patients. In normal controls the median NaL1CT was 244; range 134 to 390 mol liter cells' hr', NaLiCT was elevated in all patient groups compared to normal controls. This increase P < 0.01 compared to DNP-and RD b P < 0.01 compared to DNPc P < 0.001 compared to DNP+ and DNPd p < 0.001 compared to DNP+ and RD P < 0.001 compared to DNP+ 1P < 0.01 compared to DNPwas only significant for both the diabetic patient groups (P < 0.01). NaL1CT in patients with DNP (median 314; range 162 to 676) was not different from that in patients without DNP (median 325; range 189 to 627) or RD (median 300; range 142 to 655; Fig. 5 ). NaLiCT in patients with overt DNP (median 326; range 162 to 676) was not different from that of patients with incipient DNP (median 284; range 217 to 649). Also in patients with glomerular (median 321; range 142 to 614) or non-glomerular renal disease (median 291; range 142 to 655) NaLiCT was not different. In the two patients with renal disease secondary to hypertension, NaLiCT was respectively 211 and 271 imol liter cells hr. No correlations were found between NaLiCT and age, HbAIC, creatinine, AER, body weight, MAP and total cholesterol (measured only in the diabetic patients). Of the 16 patients with DNP and hypertension, three (19%) had a NaLiCT > 400 mol . liter cells' hr (the upper normal limit), whereas 8 of 23 (35%) of the patients with DNP without hypertension had a NaLiCT above this limit. This indicates that hypertension in patients with DNP is not associated with an increased NaLiCT. Of the 50 patients with hypertension, 47 were receiving antihypertensive therapy. Monotherapy was used in 23 patients (ACE inhibitors in 7, p-blockers in 10, diuretics in 3 and calcium entry blockers in 3). A two drug regimen was used in 20 patients (ACE inhibitors or p-blockers combined with a diuretic in 2 and 15 patients, respectively, and a p-blocker combined with a calcium entry blocker in 3 patients). Triple therapy was used by four patients. The type of antihypertensive drug or the combination used had no influence on NaLiCT. Antihypertensive treatment was not discontinued before the NaLiCT measurement. 93±5" 101±10 107±l1 8S±8 Data are given as mean SD; ranges are given in parenthesis. P < 0.001
NaLiCT and familial diabetes To study whether an elevated NaLiCT clustered with familial occurrence of DNP 16 probands with long standing (>15 years) type 1 diabetes mellitus who had at least one sib also with type 1 diabetes mellitus for more than 15 years could be selected. The eight probands with DNP had nine sibs with diabetes, of whom five had DNP, in contrast to only one out of nine sibs of the eight probands without DNP. This increased prevalence of DNP in sibs of probands with DNP indicates a trend towards familial clustering of DNP, which however, was not statistically significant. Table 3 shows the clinical and metabolic data of the patients studied. Three groups of siblings were formed: one with probands and sibs concordant for the presence of nephropathy (DNP+/+), a second group with probands and sibs concordant for absence of nephropathy (DNP-/-) and a group with probands and sibs discordant for nephropathy (DNP+/-). Age at onset of diabetes was significantly lower in the DNP +1+ group. Diabetes duration was the same in all groups. Diastolic blood pressure and serum creatinine were also significantly increased in the DNP+/+ group, The correlation between NaLiCT in probands and sibs was not significant (r = 0.48; P 0.06), which confirms the weak genetic basis of NaLiCT. NaLiCT did not differ between DNP+/+ (median 307; range 217 to 428 mol . liter cells' hr') and DNP-/-(median 279; range 189 to 442), but was significantly increased in DNP+/-(median 468; range 310 to 649; P < 0.02; Fig. 6 ). The two highest NaLiCT levels in this group come from a sister and brother with and without nephropathy, respectively. In two DNP+/+ families and three DNP-/-families a positive history of parental hypertension was present. In four families the history of parental hypertension was not clear (three in the DNP-/-and one in the DNP+/+). These data do not permit a conclusion whether hypertension was more prevalent in parents of sibs with DNP.
Discussion
As already mentioned, it is at present not known which factors determine the development of nephropathy in Type 1 (insulin-dependent) diabetes mellitus. Although metabolic control is certainly an important factor [3, 4] , it is generally accepted that other factors are also involved. Recently, the predisposition to essential hypertension [8, 10, 11] was put forward as an important risk factor. This was based on the presence of an increased prevalence of two indicators for a genetic predisposition to essential hypertension in patients with DNP: a) hypertension in non-diabetic parents and b) an increased NaLICT. As indicated in Table 4 this increased activity of NaLiCT was initially reported in patients with overt DNP [10, 11] and subsequently also in patients with incipient DNP [12] . Furthermore, it was found that normoalbuminuric diabetic patients with an increased NaLiCT had evidence for glomerular hyperfiltration [13] . This led to the conclusion that an increased NaLiCT might be useful as an early predictor of nephropathy in type 1 diabetes. Several mechanisms have been proposed to explain the association between predisposition to essential hypertension and DNP [10] [11] [12] . It has been hypothesized that predisposition to essential hypertension is related to genetically determined abnormalities in renal hemodynamics [26] [27] [28] . These derangements in combination with diabetes-associated alterations in renal hemodynamics, together with poor metabolic control, could then lead to the development of DNP. The findings of Carr et at [131 are compatible with this contention, because they could identify within a group of normoalbuminuric type 1 diabetes a subgroup of patients with hyperfiltration, by means of an increased NaLiCT. A second explanation that has been raised for the association between DNP and elevated NaLiCT is that the NaLiCT activity is at least functionally related to the sodium-hydrogen antiport [29-3 1] . The activity of the Na/H antiporter is responsible for the proximal tubular sodium-reabsorption and regulation of cell pH, cell volume and vascular tone [30, 31] . If an increased NaLiCT reflects an elevated activity of the Na/H antiporter, it may be associated with increased renal sodium retention, leading to an expanded extracellular volume [32] and increased vascular tone. This idea is consistent with the finding of sodium retention in some patients with diabetes [33, 341. Irrespective of the responsible mechanism, an increased systemic arterial pressure can lead to an increased intraglomerular pressure because most diabetic patients show, dependent of their actual metabolic control, a preglomerular vasodilation which facilitates the transmission of systemic hypertension to the glomerular capillaries. This glomerular hypertension aggravates the glomerular alterations secondary to diabetes, and may thereby lead to the full clinical picture of DNP. A third explanation that has been advocated is that an increased NaLiCT is a marker for an increased peripheral insulin resistance [35] , which itself is associated with hyperlipidemia, hypertension and increased cardiovascular mortality [36] . Furthermore, an increased NaLiCT is associated with higher levels of cholesterol and VLDL-triglycerides and with lower levels of HDL-cholesterol [37] [38] [39] . This more atherogenic lipoprotein profile may be a permissive factor for the development of DNP.
Elving el a!: Na/Li countertransport in diabetic nephropathy 867 The enthusiasm about the initial idea that an increased NaLiCT might be useful to identify patients at risk for the development of DNP has been tempered by more recent findings. Our study does not confirm the findings of the initial reports [10] [11] [12] [13] . We found no differences in NaL1CT between patients with or without DNP, and with non-diabetic patients with other renal diseases, although patients with diabetes mellitus had higher NaL1CT values than healthy control subjects. Since the majority of the patients in the initial studies had overt DNP and hypertension, we analyzed whether patients with hypertension or overt DNP had higher NaLiCT activity. This was found not to be the case. After we had finished our studies [15, 161 results were published by English and Danish investigators on the relation between a genetic predisposition to hypertension and the occurrence of DNP [17, 40] . In contrast to earlier observations [81 no difference was found in blood pressure of parents of diabetic patients with DNP, compared to parents of patients without DNP. In both studies a significant, although weak, correlation was found between NaLiCT in parents and children, in agreement with the presence of genetic determinants in NaLiCT. However, the results of NaLiCT measurements in these two studies were quite different. In the study of Walker, Tariq and Viberti [40] patients with and without DNP showed a clear difference in NaLiCT, whereas Jensen et al [17] could not find a difference in this respect, either when patients with or without DNP, or when parents of diabetic patients with or without DNP were compared. In the latter study, all patients had a higher activity of NaL1CT than healthy controls. Our study as well as the studies of Jensen et al [17] and Gall et al [41] (in type 2 diabetic patients) do not confirm that an increased NaLiCT is a genetic risk marker for the development of DNP. This is further substantiated by our finding in familial DNP, in which sib pairs concordant for the presence of DNP had the same magnitude of NaLiCT as sib pairs concordant for the absence of DNP. So, even in patients in whom the occurrence of DNP is clearly genetically determined, NaLiCT cannot be used as a marker for DNP.
Theoretically these differences in results might be due to differences in methodology of NaLiCT measurement. Several methods are used to measure NaLiCT, which vary especially for the procedure used to load the erythrocytes with lithium, that is: a) loading with 150 misi LiC1 [9, [11] [12] [13] ; b) loading with 10 mri LiC1 and nystatin [10] or c) loading with 150 mivi LiHCO3
[this study, 17, 41]. The disadvantage of loading the erythrocytes with LiCl is that it takes three hours before the intracellular lithium concentration is above 5 mmol liter cells ' (Fig.  1) , at which concentration the NaLiCT is saturated [20] . By adding nystatin to the incubation medium, the lithium influx is enhanced, because nystatin disturbs the integrity of the cell membrane and thereby increases the permeability for ions. It is not known whether this rather drastic procedure might have an effect on the function of the delicate transmembrane transporters. We therefore chose LiHCO3 as loading medium, as originally described by Ibsen et al [20] . Using these conditions lithium is transported into the cell via anion exchange [24] . This is a much faster process than exchange diffusion, which takes place during loading with LiCI. A second difference between our method and those applied by others [10- 131 is that the sodium independent efflux is measured in a KC1 medium instead of a MgCl2 medium as originally described by Canessa et at [9] .
Previous studies by Ibsen et al [20] have shown that this sodium-independent spontaneous lithium efflux is identical in KC1, MgCI2 and choline chloride medium. In the first four studies listed in Table 4 , showing that the NaLiCT was elevated in DNP, LiCl was used as loading medium, whereas in the last two studies, in which LiHCO3 was used, no differences between patients with and without DNP were found. This might suggest that the outcome of these studies is influenced by the method used to measure NaLiCT. Several observations, however, indicate that both methods are equally reliable. First, our value for NaLiCT in normal controls is comparable to that reported in the literature (Table 4 ) [22] . Second, both loading procedures achieve an intracellular lithium concentration above the critical value at which the countertransport is saturated [201. The final proof that differences in methodology are not responsible for the observed differences in results, comes from our observation that the NaLiCT measured after both loading procedures is identical (Table 1, Fig. 4) .
We cannot offer a clear explanation for the differences in results. If one analyzes the different studies with regard to the proportion of patients who have a NaLiCT above the upper limit of normal controls, that is, 400 mol liter cells' hr' (Table 4) , one finds identical values in patients with nondiabetic renal diseases (studies 2 and 6) and in patients without DNP (studies ito 4 and 6) except for study 5. In the last study, however, the median value for the NaLiCT is rather high in all groups, and a considerable proportion of the normal controls (25%) has a NaLiCT above 400 mol liter cells hr'. This discrepancy might be explained by a difference in time of blood sampling. In the Danish study, blood was collected in the afternoon. It was recently reported that NaLiCT has a diurnal rhythm, the activity increasing during the day [42] . The major difference for the proportion of patients with a NaLiCT > 400 mo1 liter cells hr' in the various studies listed in Table   4 , is observed in patients with diabetic nephropathy. It is known that NaLiCT can be influenced by several exogenous factors such as oral contraceptives, hypokalemia [43] , pregnancy [441, thyroid hormones [45] , factors that influence the intracellular calcium concentration [46] , exercise [47] , lead [48] , prednisone [491, and most importantly, lipid profiles [38, 39] . Recently, it was shown that LDL-apheresis induces an acute change in NaLiCT [50] . Although it has been claimed that impaired kidney function can increase NaL1CT [51, 52] , others could not confirm these data [53, 54] . Since the NaLiCT in our group of patients with non-diabetic renal disease was comparable to that in patients without DNP, irrespective of a much higher serum creatinine in the first group, impaired kidney function can be excluded as an important factor influencing NaLiCT. Differences in lipid profiles might be an explanation for the differences observed with regard to NaLiCT in DNP. It is known that serum lipid profiles [38, 391 , as well as the lipid composition of the cell membrane [55] influence NaLiCT. The importance of this is reflected by a recent study of Jones et a! [12] , who concluded that in inicroalbuminuric diabetic patients, NaLiCT is related to total and VLDL triglycerides independent of HbA,, AER, insulin dose and body mass index. They did not analyze whether NaLiCT was still elevated in microalbuminuric patients when differences in the lipid profile were taken into account. It is known that even in microalbuminuric patients the lipid profiles are disturbed [56] . In most [10, 11, 13, this studyl, Table 5 . Influence of low sodium diet (3 g NaCllday) and high sodium diet (12 g NaCI/day) on urinary sodium excretion (UNaV) fractional sodium excretion (FENa), fractional lithium excretion (FELl) and sodium-lithium countertransport (NaLiCT) in 10 normal controls but not all studies [12, 171 on the relation between NaLiCT and DNP no correlation was found between MAP and/or antihypertensive treatment and the magnitude of the NaLiCT. By contrast this correlation is in general present in patients with essential hypertension [57, 58] . This difference is remarkable and again raises the possibility that the increase in NaLiCT in DNP found by some investigators is secondary to non-genetic, exogenous factors. Unfortunately, our studies were not designed to study the potential effect of exogenous factors on NaLiCT, therefore we cannot evaluate a possible contribution of the various mentioned factors on the magnitude of the NaLiCT in our patients. After the finding that the NaLiCT was elevated in DNP, the hypothesis has been put forth that this was an indicator for an increased activity of the sodium-proton exchanger in the renal proximal tubule. In essential hypertension an inverse correlation was described between red cell NaLiCT and fractional lithium excretion (FELl) [32] , an indicator for proximal tubular sodium reabsorption [59] . In vitro studies, however, have shown that both cation transport systems show a differential sensitivity to amiloride, the Na/H antiporter being sensitive in contrast to NaLiCT [60, 61] . We analyzed the relation between NaLiCT and FEL. by measuring both parameters in healthy volunteers after high and low dietary salt intake [62] . As expected the FELl was clearly influenced by the amount of dietary salt intake (Table 5 ), but the NaLiCT was not influenced. During high and low salt intake both, we found no correlation between NaLiCT and FELl, while FELl was significantly correlated with the fractional sodium excretion under both diet regimens (r 0.65; P < 0.05). This confirms earlier studies in which no relation was found between NaLiCT and proximal tubular sodium handling [29, 63, 64] . These in vitro and in vivo findings do not support the hypothesis that NaLiCT is functionally related to proximal tubular Na/H exchange. This is further substantiated by the very recent finding that NaLiCT is not linked to the Na/H antiporter gene [65] ,
In conclusion, NaLiCT is increased in patients with type 1 diabetes mellitus, probably due to exogenous factors. It cannot be used, however, to detect patients at risk for the development of diabetic nephropathy in these patients.
